Trastuzumab Beyond Progression in Retrospective Analyses: An Issue of Equal Opportunities

Por Montemurro, Filippo, Redana, Stefania, Geuna, Elena, Milani, Andrea, Rossi, Valentina, Martinello, Rossella, Valabrega, Giorgio, Aglietta, Massimo
Publicado em 2011

Vinorelbine-based salvage therapy in HER2-positive metastatic breast cancer patients progressing during trastuzumab-containing regimens: a retrospective study

Por Montemurro, Filippo, Redana, Stefania, Nolè, Franco, Donadio, Michela, Jacomuzzzi, Maria Elena, Valabrega, Giorgio, Viale, Giuseppe, Sapino, Anna, Aglietta, Massimo
Publicado em 2008

Trastuzumab with either docetaxel or vinorelbine as first-line treatment for patients with HER2-positive advanced breast cancer: a retrospective comparison

Por Redana, Stefania, Donadio, Michela, Nolè, Franco, Jacomuzzi, Maria Elena, Beano, Alessandra, Martinello, Rossella, Sapino, Anna, Viale, Giuseppe, Aglietta, Massimo, Montemurro, Filippo
Publicado em 2010

Moderate Immunohistochemical Expression of HER-2 (2+) Without HER-2 Gene Amplification Is a Negative Prognostic Factor in Early Breast Cancer

Por Rossi, Valentina, Sarotto, Ivana, Maggiorotto, Furio, Berchialla, Paola, Kubatzki, Franziska, Tomasi, Nicoletta, Redana, Stefania, Martinello, Rossella, Valabrega, Giorgio, Aglietta, Massimo, Ponzone, Riccardo, Montemurro, Filippo
Publicado em 2012

Underuse of Anthracyclines in Women with HER-2(+) Advanced Breast Cancer

Por Montemurro, Filippo, Rossi, Valentina, Nolè, Franco, Redana, Stefania, Donadio, Michela, Martinello, Rossella, Verri, Elena, Valabrega, Giorgio, Rocca, Maria Cossu, Jacomuzzi, Maria Elena, Viale, Giuseppe, Sapino, Anna, Aglietta, Massimo
Publicado em 2010